相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Health-Related Quality of Life of Patients with Acute Myeloid Leukemia: A Systematic Literature Review
Ellen E. Korol et al.
ONCOLOGY AND THERAPY (2017)
New drug approvals in acute myeloid leukemia: what's the best end point?
E. Estey et al.
LEUKEMIA (2016)
Incorporating Patient Preferences Into Drug Development and Regulatory Decision Making: Results From a Quantitative Pilot Study With Cancer Patients, Carers, and Regulators
D. Postmus et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Developing a Patient-Centered Benefit-Risk Survey: A Community-Engaged Process
Ilene L. Hollin et al.
VALUE IN HEALTH (2016)
Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force
A. Brett Hauber et al.
VALUE IN HEALTH (2016)
Patient Preferences in Regulatory Benefit-Risk Assessments: A US Perspective
F. Reed Johnson et al.
VALUE IN HEALTH (2016)
Acute myeloid leukaemia
Asim Khwaja et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
A Framework for Instrument Development of a Choice Experiment: An Application to Type 2 Diabetes
Ellen M. Janssen et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2016)
Perceived Barriers and Potential Strategies to Improve Self-Management Among Adults with Type 2 Diabetes: A Community-Engaged Research Approach
Tanjala S. Purnell et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2016)
How I treat refractory and early relapsed acute myeloid leukemia
Felicitas Thol et al.
BLOOD (2015)
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study
Farhad Ravandi et al.
LANCET ONCOLOGY (2015)
A phase II exercise randomized controlled trial for patients with acute myeloid leukemia undergoing induction chemotherapy
S. M. H. Alibhai et al.
LEUKEMIA RESEARCH (2015)
How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the US Food and Drug Administration
Pat Furlong et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
Incorporating patient-preference evidence into regulatory decision making
Martin P. Ho et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2015)
MEASURING TREATMENT PREFERENCES OF PATIENTS DIAGNOSED WITH IDIOPATHIC PULMONARY FIBROSIS USING BEST-WORST SCALING
G. F. Camponeschi et al.
VALUE IN HEALTH (2015)
Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age
Shabbir M. H. Alibhai et al.
JOURNAL OF GERIATRIC ONCOLOGY (2015)
Defining and Treating Older Adults with Acute Myeloid Leukemia who Are ineligible for intensive Therapies
Kristen Pettit et al.
FRONTIERS IN ONCOLOGY (2015)
Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia
Enrico De Astis et al.
ANNALS OF HEMATOLOGY (2014)
Cancer Treatment and Survivorship Statistics, 2014
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
A Community-Engaged Approach to Quantifying Caregiver Preferences for the Benefits and Risks of Emerging Therapies for Duchenne Muscular Dystrophy
Holly L. Peay et al.
CLINICAL THERAPEUTICS (2014)
Patient preferences for stopping tyrosine kinase inhibitors in chronic myeloid leukemia
D. Sanford et al.
CURRENT ONCOLOGY (2014)
Finding new bearings: a qualitative study on the transition from inpatient to ambulatory care of patients with acute myeloid leukemia
Rinat Nissim et al.
SUPPORTIVE CARE IN CANCER (2014)
High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM
C. Kelaidi et al.
ANNALS OF HEMATOLOGY (2013)
Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients
Mauricette Michallet et al.
CANCER (2013)
Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force
F. Reed Johnson et al.
VALUE IN HEALTH (2013)
Leukaemia update. Part 1: diagnosis and management
Nicholas F. Grigoropoulos et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Physician's Attitude Towards Treatment of Older Patients and the Choice of Therapy
Felicetto Ferrara
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2013)
Survival for older patients with acute myeloid leukemia: a population-based study
Betul Oran et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations
Joanna Coast et al.
HEALTH ECONOMICS (2012)
Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study
Hagop Kantarjian et al.
LANCET ONCOLOGY (2012)
Patients' preferences for treatment outcomes for advanced non-small cell lung cancer: A conjoint analysis
John F. P. Bridges et al.
LUNG CANCER (2012)
Association of anemia and cognitive dysfunction in patients with acute myelogenous leukemia and myelodysplastic syndrome
Susan M. Wood et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Acute Myeloid Leukaemia Optimal Management and Recent Developments
Luis Villela et al.
DRUGS (2011)
FLANG salvage chemotherapy is an effective regimen that offers a safe bridge to transplantation for patients with relapsed or refractory acute myeloid leukemia
Ki-Seong Eom et al.
MEDICAL ONCOLOGY (2011)
Conjoint Analysis Applications in Health-a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force
John F. P. Bridges et al.
VALUE IN HEALTH (2011)
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Doehner et al.
BLOOD (2010)
Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification: The ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report
Margaret Rothman et al.
VALUE IN HEALTH (2009)
What Are the Endpoints of Therapy for Acute Leukemias? Old Definitions and New Challenges
B. Douglas Smith et al.
CLINICAL LYMPHOMA & MYELOMA (2009)
Acute myeloid leukemia:: Epidemiology and etiology
Barbara Deschler et al.
CANCER (2006)
Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials
CA Townsley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
BD Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Assessment of differences in patient populations selected for or excluded from participation in clinical phase III acute myelogenous leukemia trials
C Mengis et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
分享论文
